| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |